Delfi Diagnostics
Developer of a blood test system designed for the early detection of cancer.
Biotechnology
📍 Palo Alto, CA
Founded 2019
Current Valuation
$725M
as of 2024-Q2
PRIVATE
Developer of a blood test system designed for the early detection of cancer.
Company Profile
Last Round
Series B — $100M (Jun 2024)
Fundraising Status
Series B · $100M · 2y ago
privateTotal raised $432M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $100M | Jun 2024 | — | $725M |
MedicalHealth CareBiotechnologyHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q2. Refreshed quarterly.